We have some exciting news to share! The Motley Fool UK has now become an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. We’ll be introducing a new name and brand over the coming weeks — we're very excited to share it with you and embark on this new chapter together!

2 magnificent dividend stocks for recurrent income!

Identifying dividend stocks for passive income isn’t easy. There are many things to consider but our writer reckons she’s found two great options.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Young mixed-race woman jumping for joy in a park with confetti falling around her

Image source: Getty Images

Two dividend stocks I think would be ideal for helping me build a second income stream are GSK (LSE: GSK) and Anglo American (LSE: AAL). Here’s why!

Essential healthcare

GSK is one of the biggest pharmaceutical businesses in the world with a mammoth footprint and a plethora of well-known products used everyday by millions of people.

Due to macroeconomic and geopolitical volatility, GSK shares have meandered up and down in the past 12 months. However, they’re up 10% from 1,414p at this time last year, to current levels of 1,567p.

A big reason GSK is a great passive income stock for me is its defensive nature. Healthcare is essential for all no matter the economic outlook. This can span day-to-day drugs to more complex treatments for illnesses. This defensive ability allows the business to record stable earnings and reward investors.

Speaking of returns, a dividend yield of 4% is pretty attractive and it looks well covered by earnings, which is important. However, it’s worth remembering that dividends are never guaranteed. GSK also shares look excellent value for money right now on a price-to-earnings ratio of 10.

From a risk perspective, when pharma firms experience product issues, sentiment, performance, and returns can be impacted. GSK has had this before. It has faced lawsuits due to its discontinued Zantac heartburn drug.

Overall I’d be willing to buy GSK shares for my holdings the next time I have some investable cash.

Mining giant

Anglo American is one of the biggest mining businesses in the world and mines commodities including iron ore, copper, and nickel.

To say 2023 was a difficult year for Anglo American shares would be an understatement. The shares have fallen 47% over a 12-month period from 3,493p at this time last year to current levels of 1,849p.

Commodities are cyclical, which is a big risk. Production issues can hurt performance, returns, and sentiment. This has hurt Anglo in recent times as it has downgraded production forecasts.

However, I reckon the long-term outlook is favourable. Major initiatives in the future that will require huge quantities of the commodities that Anglo mines will boost the business, in my opinion. These include decarbonisation and infrastructure building. This is in line with the world’s growing population. For example, copper is essential in building infrastructure, as well as electricity grids for new and growing cities. This increased demand should help boost performance and returns.

Speaking of returns, an enticing dividend yield of 5.5% has been pushed up by the falling share price. However, the business has an excellent track record of investor returns and an attractive policy of returning 40% of underlying earnings to investors. I’m conscious that past performance is not a guarantee of the future and policies can change, as dividends are paid at the discretion of the business.

Anglo is another stock I’d be willing to buy when I next have some spare cash to invest. A mixed 2023 hasn’t fazed me. In fact, it’s thrown up an opportunity to buy cheaper shares now on a P/E ratio of 10, ahead of any rally and bull run.

Sumayya Mansoor has no position in any of the shares mentioned. The Motley Fool UK has recommended GSK. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Aerial shot showing an aircraft shadow flying over an idyllic beach
Investing Articles

Just how cheap could IAG shares get this summer?

If the world runs out of jet fuel this summer then IAG shares could take a beating, says Harvey Jones.…

Read more »

Night Takeoff Of The American Space Shuttle
Investing Articles

Up 130% in 2026, can FTSE space stock Filtronic continue to soar?

Edward Sheldon thought that FTSE share Filtronic would do well in 2026. He wasn’t expecting it to shoot up 130%…

Read more »

British flag, Big Ben, Houses of Parliament and British flag composition
Investing Articles

Are investors still using an outdated playbook to value Lloyds shares?

Andrew Mackie looks beyond the standard rate-sensitive narrative around Lloyds shares to question whether we're missing a more resilient earnings…

Read more »

Hydrogen testing at DLR Cologne
Investing Articles

Is £15 the next stop for the Rolls-Royce share price?

Where will the Rolls-Royce share price go from here? Is a £15 price target for the next 12 months totally…

Read more »

Two female adult friends walking through the city streets at Christmas. They are talking and smiling as they do some Christmas shopping.
Investing Articles

How much is £7,620 saved in a Cash ISA a decade ago worth today?

Cash ISA savers have received an average of 4% over the last decade, but Harvey Jones says the average Stocks…

Read more »

Close-up as a woman counts out modern British banknotes.
Investing Articles

702 shares in this FTSE 100 stalwart earn a £100 a month second income

Unilever shares come with an unusually high dividend yield. Should investors looking for a second income grab the opportunity with…

Read more »

UK coloured flags waving above large crowd on a stadium sport match.
Investing Articles

This surging FTSE 100 share just hit £201! Will it ever split its stock? 

This high-quality FTSE 100 stock is up by a staggering 4,050% in the past 10 years. Why hasn't it split…

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

Just over £13 after its Q1 results, here’s why HSBC shares still look a bargain-basement buy for me anywhere below £20.68

HSBC shares have surged, but fresh results hint the market may still be missing a major value opportunity that long…

Read more »